Cyberonics Announces CE Mark Approval Of The AspireSR(TM) Generator For VNS Therapy(R)

Proprietary Technology Provides Automatic Stimulation upon Seizure Detection HOUSTON, Feb. 20, 2014 -- (Healthcare Sales & Marketing Network) -- Cyberonics, Inc. (CYBX) announced today the CE Mark (Conformité Européenne) approval in Euro... Devices, RegulatoryCyberonics, AspireSR generator, VNS Therapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news